Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myricetin: targeting signaling networks in cancer and its implication in chemotherapy
Zeeshan Javed, Khushbukhat Khan, Jesús Herrera‐Bravo, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications
Shumaila Ijaz, Javed Iqbal, Banzeer Ahsan Abbasi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114687-114687
Open Access | Times Cited: 63
Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy
Sara Motyka, Karolina Jafernik, Halina Ekiert, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114145-114145
Open Access | Times Cited: 68
Recent advances in the therapeutic potential of emodin for human health
Javad Sharifi‐Rad, Jesús Herrera‐Bravo, Senem Kamiloğlu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113555-113555
Open Access | Times Cited: 54
Recent updates on anticancer mechanisms of polyphenols
Eshita Sharma, Dharam Chand Attri, Priyanka Sati, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 54
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation
Muhammad Javed Iqbal, Zeeshan Javed, Jesús Herrera‐Bravo, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 45
Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms
Carla Varela, Catarina Melim, Beatriz Guapo Neves, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Anticancer properties of bromelain: State-of-the-art and recent trends
Raffaele Pezzani, Manuel Jiménez-Garcia, Xavier Capó, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 35
Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
Priya Chaudhary, Debasis Mitra, Pradeep K. Das Mohapatra, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 5, pp. 104680-104680
Open Access | Times Cited: 33
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 32
Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
Arshad Husain Rahmani, Ahmad Almatroudi, Khaled S. Allemailem, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9665-9665
Open Access | Times Cited: 24
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy
Madhu Kamle, Shikha Pandhi, Sadhna Mishra, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 7
Flavonoids Are Intra- and Inter-Kingdom Modulator Signals
Elisa Ghitti, Eleonora Rolli, Elena Crotti, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2479-2479
Open Access | Times Cited: 26
Natural essential oils as a new therapeutic tool in colorectal cancer
Stefania Garzoli, Pedro Alarcón, G. A. Seitimova, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Design, synthesis, bioactivity and mechanism of action of novel myricetin derivatives containing amide and hydrazide
Xiao Cao, Fang Liu, Bangcan He, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 4, pp. 104588-104588
Open Access | Times Cited: 15
Design, synthesis and bioactivity of myricetin derivatives for control of fungal disease and tobacco mosaic virus disease
Xiao Cao, Bangcan He, Fang Liu, et al.
RSC Advances (2023) Vol. 13, Iss. 10, pp. 6459-6465
Open Access | Times Cited: 15
An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms
Muhammad Torequl Islam, Miquel Martorell, Carlos González-Contreras, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer
Noor Bahadar, Sher Bahadar, Abdul Sajid, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Comprehensive In Silico Analysis of Flavonoids in Breast Cancer Using Molecular Docking, ADME, and Molecular Dynamics Simulation Approach
Dheeraj Gupta, Kavita Apte, Puzhakkal Abhirami, et al.
Peptide Science (2025) Vol. 117, Iss. 1
Closed Access
Phytochemical Insights into Flavonoids in Cancer: Mechanisms, Therapeutic Potential, and the Case of Quercetin
Piero Alex Silva-Pinto, Janaína Teixeira Costa de Pontes, Brigitte Aguilar-Morón, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42682-e42682
Open Access
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the art
Giorgio Monteleone, Paolo Cameli, Francesco Bonella
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240147-240147
Open Access
Myricetin induces cell cycle arrest and suppresses tumorigenesis in bladder cancer through the interaction of EGFR-Ras and Fas signaling pathways
Xiumin Xu, Hongtao Yu, Yuesheng Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Amplifying therapeutic potential through optimization of bioavailability of poorly soluble flavonols via albumin-based nanoparticles
Shayeri Chatterjee Ganguly, R. Maity, P. K. Manna, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-21
Closed Access
Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule
Parteek Prasher, Mousmee Sharma, Amit Sharma, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114332-114332
Open Access | Times Cited: 12
A comprehensive review on traditional uses, phytochemistry and pharmacological properties of Paeonia emodi Wall. ex Royle: current landscape and future perspectives
Nida Zahra, Javed Iqbal, Muhammad Arif, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top